{"ModuleTitle": "Company Description", "CompanyName": "AMAG Pharmaceuticals, Inc.", "Symbol": "AMAG", "Address": "1100 WINTER STREET, WALTHAM, Massachusetts, 02451, United States of America", "Phone": "6174983300", "Industry": "Major Pharmaceuticals", "Sector": "Health Care", "Region": "North America", "CompanyDescription": "AMAG Pharmaceuticals, Inc., a Delaware corporation, was founded in 1981. We are\r\na pharmaceutical company focused on bringing innovative products to patients\r\nwith unmet medical needs by leveraging our development and commercial expertise\r\nto invest in and grow our pharmaceutical products and product candidates across\r\na range of therapeutic areas. Our currently marketed products support the health\r\nof patients in the areas of hematology and maternal and women's health,\r\nincluding Feraheme\u00ae (ferumoxytol injection) for intravenous (\"IV\") use, Makena\u00ae\r\n(hydroxyprogesterone caproate injection) auto-injector, Intrarosa\u00ae (prasterone)\r\nvaginal inserts and Vyleesi\u00ae(bremelanotide injection). In addition to our\r\napproved products, our portfolio includes two product candidates, AMAG-423\r\n(digoxin immune fab (ovine)), which is being studied for the treatment of severe\r\npreeclampsia, and ciraparantag, which is being studied as an anticoagulant\r\nreversal agent.&nbsp;&nbsp;... <a href=\"http://secfilings.nasdaq.com/edgar_conv_html/2007/05/08/0001104659-07-037032.html#FIS_NOTES_TO_FINANCIAL_STATEMENT\" target=\"_blank\">More</a> ...&nbsp;&nbsp;\r\n", "KeyExecutives": [{"name": "Anthony Casciano", "title": "Chief Operating Officer"}, {"name": "Brian Piekos", "title": "Chief Financial & Accounting Officer"}, {"name": "Brian Robinson", "title": "Senior Vice President-Medical Affairs"}, {"name": "Joseph D. Vittiglio", "title": "Secretary, Chief Business Officer & EVP"}, {"name": "Scott D. Myers", "title": "President, Chief Executive Officer & Director"}], "Number_of_employees": ["NO INFO"], "Subsidiaries": ["NO INFO"]}